|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 36215 |
FusionGeneSummary for ST13_ST8SIA3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ST13_ST8SIA3 | Fusion gene ID: 36215 | Hgene | Tgene | Gene symbol | ST13 | ST8SIA3 | Gene ID | 6767 | 51046 |
| Gene name | ST13, Hsp70 interacting protein | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 | |
| Synonyms | AAG2|FAM10A1|FAM10A4|HIP|HOP|HSPABP|HSPABP1|P48|PRO0786|SNC6 | SIAT8C|ST8SiaIII | |
| Cytomap | 22q13.2 | 18q21.31 | |
| Type of gene | protein-coding | protein-coding | |
| Description | hsc70-interacting proteinHsp70-interacting proteinaging-associated protein 2heat shock 70kD protein binding proteinprogesterone receptor-associated p48 proteinputative tumor suppressor ST13renal carcinoma antigen NY-REN-33suppression of tumorigenic | sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferaseSIAT8-CST8 alpha-N-acetylneuraminate alpha-2,8-sialyltransferase 3alpha-2,8-sialyltransferase 8Calpha-2,8-sialyltransferase IIIsialyltransferase 8C (alpha2,3Galbeta1,4GlcNAcalpha 2,8-sial | |
| Modification date | 20180523 | 20180519 | |
| UniProtAcc | P50502 | O43173 | |
| Ensembl transtripts involved in fusion gene | ENST00000216218, | ENST00000324000, ENST00000590600, | |
| Fusion gene scores | * DoF score | 3 X 3 X 3=27 | 2 X 2 X 2=8 |
| # samples | 4 | 2 | |
| ** MAII score | log2(4/27*10)=0.567040592723894 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(2/8*10)=1.32192809488736 | |
| Context | PubMed: ST13 [Title/Abstract] AND ST8SIA3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | ST8SIA3 | GO:0001574 | ganglioside biosynthetic process | 10766765 |
| Tgene | ST8SIA3 | GO:0006486 | protein glycosylation | 10766765 |
| Tgene | ST8SIA3 | GO:0006491 | N-glycan processing | 10766765|26192331 |
| Tgene | ST8SIA3 | GO:0009100 | glycoprotein metabolic process | 9826427|10766765 |
| Tgene | ST8SIA3 | GO:0009311 | oligosaccharide metabolic process | 10766765 |
| Tgene | ST8SIA3 | GO:1990743 | protein sialylation | 26192331 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | ESCA | TCGA-L5-A43E-01A | ST13 | chr22 | 41244298 | - | ST8SIA3 | chr18 | 55019707 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-5UTR | ENST00000216218 | ENST00000324000 | ST13 | chr22 | 41244298 | - | ST8SIA3 | chr18 | 55019707 | + |
| 5CDS-intron | ENST00000216218 | ENST00000590600 | ST13 | chr22 | 41244298 | - | ST8SIA3 | chr18 | 55019707 | + |
Top |
FusionProtFeatures for ST13_ST8SIA3 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ST13 | ST8SIA3 |
| One HIP oligomer binds the ATPase domains of at leasttwo HSC70 molecules dependent on activation of the HSC70 ATPase byHSP40. Stabilizes the ADP state of HSC70 that has a high affinityfor substrate protein. Through its own chaperone activity, it maycontribute to the interaction of HSC70 with various targetproteins (By similarity). {ECO:0000250}. | Catalyzes the transfer of sialic acid from a CMP-linkedsialic acid donor onto the terminal sialic acid of an acceptorthrough alpha-2,8-linkages. Is active with alpha-2,3-linked,alpha-2,6-linked and alpha-2,8-linked sialic acid of N-linkedoligosaccharides of glycoproteins and glycolipids. Displayspreference for substrates with alpha-2,3-linked terminal sialicacid. It can form polysialic acid in vitro directly on alpha-2,3-,alpha-2,6-, or alpha-2,8-linked sialic acid.{ECO:0000269|PubMed:10766765, ECO:0000269|PubMed:26192331,ECO:0000269|PubMed:9826427}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ST13_ST8SIA3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ST13_ST8SIA3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| ST13 | CD101, OLFM2, HSPA1A, DAPK1, CDC42, RYK, TTR, VAV2, ELAVL1, CDK2, IRAK1, CXCR2, CXCR4, NOS3, APOE, PSEN1, CPNE1, VCP, HSP90AA1, ALB, FN1, SMAD2, F2, CTRC, HSPA8, BAG3, CUL2, JUP, DPYSL3, MSH2, XRCC6, FUS, HSPA4, CFL2, CLIC1, DSTN, HEATR3, PACSIN2, PACSIN3, CLIC4, SUB1, NTRK1, U2AF2, CCND2 | ST8SIA3 | KLRG2, UBA52, YTHDF1, NRP2, TMEM11, ITGB5, AMIGO1, ACP2, DNAJB9, SLC30A6, CANX |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ST13_ST8SIA3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ST13_ST8SIA3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|